Coya Therapeutics Inc. (COYA)
NASDAQ · Healthcare
Coya Therapeutics Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Coya Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 43.0M, a 8.72% increase year-over-year.
- Coya Therapeutics Inc. shareholder equity for 2025 were 43.0M, a 8.72% increase from 2024.
- Coya Therapeutics Inc. shareholder equity for 2024 were 39.6M, a 11.06% increase from 2023.
- Coya Therapeutics Inc. shareholder equity for 2023 were 35.6M, a 524.56% decrease from 2022.
- Coya Therapeutics Inc. shareholder equity for 2022 were -8.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Coya Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $43 |
| 2024 | $40 |
| 2023 | $36 |
| 2022 | $-8 |
| Coya Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $43 |
| 2024-12-31 | $40 |
| 2023-12-31 | $36 |
| 2022-12-31 | $-8 |
Coya Therapeutics Inc. Shareholder Equity — FAQ
Coya Therapeutics Inc. (COYA) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COYA's shareholder equity history?
The chart and table above show Coya Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.